NEW YORK, April 11, 2014 /PRNewswire/ -- Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Oppenheimer Holdings Inc. ("Oppenheimer" or the "Company") (NYSE: OPY) for potential breaches of fiduciary duties in connection with their conduct in seeking shareholders' approval of the 2014 Incentive Plan.
Specifically, in the Proxy Statement filed by the Company with the Securities and Exchange Commission on March 28, 2014, the Board of Directors recommends that Oppenheimer's shareholders vote to approve the 2011 Incentive Stock Plan to authorize the issuance of 877,290 shares of Class A Stock. The issuance of the additional shares could have a substantial dilutive effect on the shares of Oppenheimer common stock.
Request more information now by clicking here: www.faruqilaw.com/OPY. There is no cost or obligation to you.
Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, throughout all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm's clients. To keep track of the latest securities litigation news, follow us on Twitter at www.twitter.com/MergerActivity or on Facebook at www.facebook.com/FaruqiLaw.If you own common stock in Oppenheimer and wish to obtain additional information and protect your investments free of charge, please visit us at www.faruqilaw.com/OPY or contact Juan E. Monteverde, Esq. either via e-mail at firstname.lastname@example.org or by telephone at (877) 247-4292 or (212) 983-9330. Contact:
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts